1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Autotransfusion Devices Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Autotransfusion Devices Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in surgeries requiring blood transfusion and autotransfusion
- 5.1.2 Rising adoption of autotransfusion systems in hospitals
5.2 Market Opportunities
- 5.2.1 Opportunities in integrating autotransfusion technology with robotic surgery
- 5.2.2 Increased demand in trauma and elective surgeries
5.3 Future Trends
- 5.3.1 Growth in surgical recovery applications
- 5.3.2 Use in minimally invasive surgeries
5.4 Impact of Drivers and Restraints
6. North America Autotransfusion Devices Market Regional Analysis
6.1 North America Autotransfusion Devices Market Overview
6.2 North America Autotransfusion Devices Market Revenue 2019-2028 (US$ Million)
6.3 North America Autotransfusion Devices Market Forecast Analysis
7. North America Autotransfusion Devices Market Analysis – by Type
7.1 Products
- 7.1.1 Overview
- 7.1.2 Products: North America Autotransfusion Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Accessories
- 7.2.1 Overview
- 7.2.2 Accessories: North America Autotransfusion Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Autotransfusion Devices Market Analysis – by Application
8.1 Cardiac Surgeries
- 8.1.1 Overview
- 8.1.2 Cardiac Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Orthopedic Surgeries
- 8.2.1 Overview
- 8.2.2 Orthopedic Surgeries: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Organ Transplantation
- 8.3.1 Overview
- 8.3.2 Organ Transplantation: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Trauma Procedures
- 8.4.1 Overview
- 8.4.2 Trauma Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Autotransfusion Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Trauma Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Trauma Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Ambulatory Surgery Centers
- 9.3.1 Overview
- 9.3.2 Trauma Procedures: North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Autotransfusion Devices Market – North America Analysis
10.1 North America
- 10.1.1 North America Autotransfusion Devices Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Autotransfusion Devices Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Autotransfusion Devices Market Breakdown, by Type
- 10.1.1.1.2 US: North America Autotransfusion Devices Market Breakdown, by Application
- 10.1.1.1.3 US: North America Autotransfusion Devices Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Autotransfusion Devices Market Breakdown, by Type
- 10.1.1.2.2 Canada: North America Autotransfusion Devices Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Autotransfusion Devices Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Autotransfusion Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Autotransfusion Devices Market Breakdown, by Type
- 10.1.1.3.2 Mexico : North America Autotransfusion Devices Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Autotransfusion Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Autotransfusion Devices Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 BD
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Braile Biomedica
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Fresenius SE & Co. KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Haemonetics Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 LivaNova PLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Redax S.p.A.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 SARSTEDT AG and Co. KG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Teleflex Incorporated
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Zimmer Biomet
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights